These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18848874)

  • 21. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
    Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
    Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
    Yamasaki K; Kwok PC; Fukushige K; Prud'homme RK; Chan HK
    Int J Pharm; 2011 Nov; 420(1):34-42. PubMed ID: 21864662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro-particle corrugation, adhesion and inhalation aerosol efficiency.
    Adi S; Adi H; Tang P; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2008 Sep; 35(1-2):12-8. PubMed ID: 18586091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
    Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
    Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM; Mescher A; Schroettner H; Achelis L; Walzel P; Urbanetz NA
    Eur J Pharm Biopharm; 2012 Sep; 82(1):194-204. PubMed ID: 22595133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of solid corrugated particles to enhance powder aerosol performance.
    Chew NY; Chan HK
    Pharm Res; 2001 Nov; 18(11):1570-7. PubMed ID: 11758765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact angles as an alternative way to improve aerosolisation of powders for inhalation?
    Adi S; Tong Z; Chan HK; Yang R; Yu A
    Eur J Pharm Sci; 2010 Oct; 41(2):320-7. PubMed ID: 20615465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.
    Shetty N; Zeng L; Mangal S; Nie H; Rowles MR; Guo R; Han Y; Park JH; Zhou QT
    Pharm Res; 2018 Jan; 35(1):7. PubMed ID: 29294198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
    Rattanupatam T; Srichana T
    Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
    Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach.
    Sou T; Orlando L; McIntosh MP; Kaminskas LM; Morton DA
    Int J Pharm; 2011 Dec; 421(2):220-9. PubMed ID: 21963471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W; Nokhodchi A
    Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
    Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
    Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T; Li J; Morton DA; Zhou QT; Larson I
    J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.